Meek David D. 4
4 · Mirati Therapeutics, Inc. · Filed Dec 21, 2022
Insider Transaction Report
Form 4
Meek David D.
DirectorChief Executive Officer
Transactions
- Award
Common Stock
2022-12-19+35,425→ 69,587 total - Sale
Common Stock
2022-12-21$40.41/sh−4,616$186,552→ 64,971 total
Footnotes (3)
- [F1]Award of Performance Stock Units ("PSUs"). 1/3 of the PSUs have vested on December 19, 2022 (one week after the "Achievement Date" of December 12, 2022). 1/3 of the remaining shares will vest on the one year anniversary of the Achievement Date and the remaining 1/3 will vest on the two year anniversary of the Achievement Date, subject to Mr. Meek's continuous service.
- [F2]Includes 64 shares acquired under the ESPP Purchase on 5/31/2022 and 41 shares acquired under the ESPP purchase on 11/30/2022.
- [F3]Represents shares sold by the Company to satisfy the tax withholding obligation associated with the vesting of a portion of the PSUs referenced in Footnote 1.